Cardiawave joins @MedTechFrance! 🇫🇷
A great opportunity to build partnerships and accelerate patient access to the non-invasive solution #Valvosoft® for aortic stenosis. 🫀✨
Cardiawave CEO Carine Schorochoff interviewed this morning on @bfmbusiness Good Morning Business🎥Discussing non-invasive Valvosoft® technology to treat aortic stenosis.
Watch the interview: https://t.co/zw2prJfPzA
Our fundraising is closing June 30: https://t.co/H9LSer7Lrf
First Cardiawave treatments now in routine clinical practice in Germany 🇩🇪
No catheter. No surgery. Just non-invasive ultrasound for aortic stenosis 🎯
Grateful for clinicians’ trust and feedback 🙏
https://t.co/KrqsuhG74W
#MedTech#Cardiology#Innovation
Great energy at #EuroPCR2026! ✨ Thanks for stopping by to discover Valvosoft® and meet the team 🤝 Special thanks to Azeem Latib & Won‑Keun Kim for their insights 🎤 https://t.co/OR14f4Yo4k • https://t.co/uTomvvHAG1 Let’s keep the momentum! 🚀 #MedTech#Cardiology#Innovation
Strong momentum for Valvosoft® in Europe 🚀
In May, 8 additional patients were successfully treated for calcific aortic stenosis across multiple centers in Europe, following Valvosoft®’s CE marking.
Great progress towards routine clinical use!
#MedTech#Cardiology#Innovation
Cardiawave at #EuroPCR 2026 🚀
2 presentations on our non-invasive ultrasound therapy #Valvosoft
✅CE-marked
✅First patients successfully treated at HEGP (Paris) in April 2026
#Cardiology#MedTech#AorticStenosis
🇪🇺✅First milestone for Valvosoft®
Last week, 2 patients were successfully treated at #HEGP since its CE marking. More to come as Valvosoft® rolls out across Europe. 🫀 @APHP#MedTech#CEmarked#Valvosoft
We are saddened by the passing of Professor Robert Levine, MD, a valued member of our Medical Advisory Board 🕊️ A pioneering leader in cardiac imaging at Massachusetts General Hospital and a devoted mentor, he will be missed. May his memory be a blessing. @MassGeneralNews
@AllianceCoeur❤️ and @CHURouen Rouen are hosting a public awareness day on April 16 with free heart‑valve screenings.
Proud to support this initiative as Valvosoft® recently obtained its CE-Marking. 💙
Proud to be featured in L’Écho Santé by @MedicenParisRegion 🎙️
At 34:56, F. Ballet calls Cardiawave “a unique technology in the world” and “a story with a promising future.”
Valvosoft® is now CE‑marked — a key milestone for our ultrasound therapy 💙
▶️ https://t.co/czBbIPS4sA
🔎 Access to medical innovation in France is slowing down — impacting patients’ chances.
At Cardiawave, we believe life‑changing cardiovascular technologies should reach patients faster and safely.
🔗 Le Monde op‑ed (FR):
https://t.co/KxpU8f9fcq
#Innovation#Cardiovascular
🚀 Proud to be featured in @BiotechFinances.
“A lean and specialized team = internalized tasks + targeted CRO support where it added value — costs under control, quality intact.”
#CEmarking achieved for our non‑invasive ultrasound therapy. 💙
🔗https://t.co/rYpsId738m
We are thrilled to welcome Hardip Thakerar to Cardiawave’s Board 🎉 A proven leader in structural heart innovation, she brings key expertise as we advance our #NIUT therapy for aortic stenosis.
#Cardiawave#MedTech#StructuralHeart#Innovation
8,000 followers on LinkedIn! 🚀
Thank you for supporting Cardiawave and our mission to bring non‑invasive ultrasound therapy to patients💙
#MedTech#Innovation
Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉
A trusted member of Cardiawave’s Medical Advisory Board, her leadership continues to inspire the cardiology community. 👏
https://t.co/HxvwvQtFbb
#Cardiology#JESFC
New interview with the @EICScalingClub 🎙️
A big thank you for this high‑quality article highlighting Cardiawave’s mission in non‑invasive cardiovascular innovation.
👉https://t.co/NYg6MMPcnn
Excited to join #JESFC2026 in Paris (Jan 14–16)!
Save the date:
📅 Jan 14, 3:30 PM: Workshop on aortic stenosis with Prof. Philippe Pibarot & Prof. Emmanuel Messas.📍Room: Maillot
✨Happy New Year!
#Cardiology#Innovation@HopitalPompidou@LavalCanada